GMMMG holds open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by GMMMG for information or approval, as appropriate.

Consultations typically run for six weeks, and comments are invited from all stakeholders across Greater Manchester. You can comment on current proposals via the links in the table below.

Please direct any questions to the secretariat at nuth.enquiries.gmmmg@nhs.net.

Title Information Feedback End Date
GM Proposal to switch Ventolin™ and generic salbutamol metered dose inhaler prescriptions to Salamol™ metered dose inhalers On behalf of the NHS Greater Manchester Green Plan Oversight Group, we now seek comments on a proposal for an active switch from Ventolin Metered-Dose Inhaler (MDI) or generic salbutamol MDI to Salamol MDI in primary care. This consultation period is open until 5pm on Monday 20th May 2024. Feedback Form May 20th, 2024
GMMMG Clinical Reference Group proposed actions from April 2024 On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the April 2024 CRG meeting. This consultation period is open until 5pm on Friday 24th May 2024. Feedback Form May 24th, 2024
Communication Standards for Opioid Medicines Prescribed at Discharge On behalf of the GMMMG Medicines Safety Group, we now seek comments on draft Communication Standards for Opioid Medicines Prescribed at Discharge. This consultation period is open until 5pm on Thursday 27th June 2024. Feedback Form June 27th, 2024